Inpatient Rehab Facility Expansion And Consolidation Will Drive Future Strength

Key Takeaways

• Strategic expansion and partnerships strengthen market presence, drive higher patient volumes, and enhance resilience amid evolving healthcare demands.
  
• Operational improvements and healthcare policy trends position post-acute and rehab offerings for sustained revenue and margin growth.
  
• Ongoing regulatory pressures, high debt, and shifts toward home-based care are compressing margins and threatening revenue stability across key Select Medical business segments.

Catalysts

Through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

• Expansion of inpatient rehab facilities, including new hospitals and bed additions in response to increasing demand from an aging population and chronic disease prevalence, is expected to drive higher patient volumes and top-line revenue growth over the next several years.
  
• Strong demand fundamentals in critical illness recovery and rehabilitation services, supported by demographic trends and hospital system needs to decompress crowded ICUs, suggest ongoing stability in patient flows, underpinning long-term revenue and cash flow growth.
  
• Continued investment in operational efficiency initiatives and system upgrades-particularly in the outpatient rehab platform-are set to enhance EBITDA margins through better scheduling, process optimization, and scalable performance improvements across a broad national clinic footprint.
  
• Increased consolidation of smaller providers and successful execution of joint venture strategies with large health systems position the company to grow market share and network density, leading to improved bargaining power, reduced referral source dependency, and more resilient earnings.
  
• Policy and payer shifts toward value-based and cost-effective care settings favor Select Medical's post-acute and rehab offerings, potentially boosting occupancy rates and reducing earnings volatility as payers and hospitals increasingly steer patients to these lower-cost, high-quality care environments.

Select Medical Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Select Medical Holdings's revenue will grow by 4.2% annually over the next 3 years.
• Analysts assume that profit margins will shrink from 2.6% today to 2.1% in 3 years time.
• Analysts expect earnings to reach $128.8 million (and earnings per share of $1.27) by about March 2029, down from $142.9 million today.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 18.0x on those 2029 earnings, up from 14.1x today. This future PE is lower than the current PE for the US Healthcare industry at 21.2x.
• Analysts expect the number of shares outstanding to decline by 3.52% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.87%, as per the Simply Wall St company report.

Risks

• Continual regulatory pressures-particularly ongoing reductions to Medicare reimbursement rates and the recent, unexpected 20% transmittal rule impacting LTACHs-are suppressing revenue growth and compressing margins, with leadership acknowledging these headwinds are likely to persist as part of their long-term financial guidance.
  
• The critical illness recovery hospital segment is facing declining revenues (down 1% YoY) and a significant drop in adjusted EBITDA (down 22% YoY), largely due to unfavorable regulatory changes in reimbursement mechanisms; ongoing pressure in this key business line threatens company-wide net margin and earnings stability.
  
• The company maintains a high debt load ($1.9 billion outstanding), and while current cash flow covers operational needs and capital expenditures, rising interest expense (up $2 million YoY) and heavy ongoing capital investments for expansion could strain free cash flow and limit financial flexibility, impacting future net earnings.
  
• Broader industry trends toward home-based care and telehealth pose a risk of reducing demand for facility-based services in both LTACHs and inpatient rehab hospitals, potentially constraining future patient volumes and limiting growth in revenue and operating margins.
  
• Persistent dependence on government (Medicare, Medicaid) and managed care payers makes Select Medical vulnerable to further payer mix shifts, rate cuts, and preauthorization denials-especially as Medicare Advantage plans grow-introducing uncertainty in patient volume, reimbursement rates, and overall revenue predictability.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of $16.62 for Select Medical Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $6.2 billion, earnings will come to $128.8 million, and it would be trading on a PE ratio of 18.0x, assuming you use a discount rate of 7.9%.
• Given the current share price of $16.25, the analyst price target of $16.62 is 2.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.